CN Patent

CN104661662A — 治疗丙型肝炎的方法

Assigned to AbbVie Inc · Expires 2015-05-27 · 11y expired

What this patent protects

本发明描述了泛基因型HCV抑制剂。本发明还涉及使用这些抑制剂治疗HCV感染的方法。

USPTO Abstract

本发明描述了泛基因型HCV抑制剂。本发明还涉及使用这些抑制剂治疗HCV感染的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104661662A
Jurisdiction
CN
Classification
—
Expires
2015-05-27
Drug substance claim
No
Drug product claim
No
Assignee
AbbVie Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.